SANKAR NAVANEETHAN to Diabetic Nephropathies
This is a "connection" page, showing publications SANKAR NAVANEETHAN has written about Diabetic Nephropathies.
Connection Strength
4.452
-
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
Score: 0.785
-
Progress in the management of patients with diabetes and chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):456-463.
Score: 0.702
-
Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1).
Score: 0.653
-
Diabetes Control and the Risks of ESRD and Mortality in?Patients?With CKD. Am J Kidney Dis. 2017 Aug; 70(2):191-198.
Score: 0.482
-
Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers? Clin J Am Soc Nephrol. 2013 Oct; 8(10):1637-9.
Score: 0.378
-
Nodular glomerulosclerosis in a non-diabetic patient: case report and review of literature. J Nephrol. 2005 Sep-Oct; 18(5):613-5.
Score: 0.218
-
Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2024 04 29; 4:CD006257.
Score: 0.199
-
Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice. J Diabetes Complications. 2023 04; 37(4):108411.
Score: 0.182
-
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2021 01; 77(1):56-73.e1.
Score: 0.154
-
Facility-Level Variations in Kidney Disease Care among Veterans with Diabetes and CKD. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1842-1850.
Score: 0.136
-
Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014 Oct; 37(10):2864-83.
Score: 0.102
-
Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis. 2014 Oct; 64(4):510-33.
Score: 0.102
-
Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up. Surg Obes Relat Dis. 2013 Jan-Feb; 9(1):7-14.
Score: 0.089
-
Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011 Oct; 58(4):536-43.
Score: 0.082
-
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006 Oct 18; (4):CD006257.
Score: 0.059
-
Antihypertensive agents in patients with diabetes: trade-off between renal and cardiovascular protection. Diabetes Educ. 2006 Jul-Aug; 32(4):596-602.
Score: 0.058
-
First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. J Nephrol. 2024 Nov; 37(8):2223-2232.
Score: 0.051
-
Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation. 2010 Dec 27; 90(12):1499-505.
Score: 0.020